001 002 003 004 005 006 007 008 009 010 011 012 013 014 015 016 017 018 019 020 021 022 023 024 025 026 027 028 029 030 031 032 033 034 035 036 037 038 039 040 041 042 043 044 045 046 047 048 049 050 051 052 053 054 055 056 057 058 059 060 061 062 063 064 065 066 067 068 069 070 071 072 073 074 075 076 077 078 079 080 081 082 083 084 085 086 087 088 089 090 091 092 093 094 095 096 097 098 099 1...

001 002 003 004 005 006 007 008 009 010 011 012 013 014 015 016 017 018 019 020 021 022 023 024 025 026 027 028 029 030 031 032 033 034 035 036 037 038 039 040 041 042 043 044 045 046 047 048 049 050 051 052 053 054 055 056 057 058 059 060 061 062 063 064 065 066 067 068 069 070 071 072 073 074 075 076 077 078 079 080 081 082 083 084 085 086 087 088 089 090 091 092 093 094 095 096 097 098 099 1...

survival in patients with HCC in two independent cohorts, and the mechanism was associated with low VEGFR-1 expression levels in HCC. Grant support: This research was supported by grants from the National Scientific Council (NSC 100-2314-B-075-051, NSC 101-2321-B075-004) and Taipei Veterans General Hospital (V101B-005, V102E2005 and V102E2-006) to YF Hu, (NSC99-3112-B-010-005-CC1, NSC1002627-B-...

Accepted by The Astrophysical Journal Received ; accepted – 2 – ABSTRACT We present a high-energy study of the intriguing COS–B γ-ray field, 2CG 075+00, in order to search for possible counterparts. New EGRET data show that the COS–B emission probably corresponds to two localized γ-ray sources, 3EG J2016+3657 and 3EG J2021+3716. Spectral fits to these EGRET sources, assuming a power-law model, ...

We present a preliminary study of the neutral kaon mixing bag parameter B K using two flavors of dynamical Wilson fermions. We determine the matrix element of the relevant ∆S 2 operator by using both the conventional approach and the so called " non-subtraction method " , and find that the latter leads to results with smaller uncertainties. After having implemented non-perturbative renormalizat...

Immunosuppression is an essential aspect of managing cardiac sarcoidosis (CS). The decision to implant a cardiovascular implantable electronic device (CIED) often made in conjunction with starting immunosuppression. It unclear if immunosuppression at the time implantation increases risk CIED infections. Since both are potentially life-saving therapies for CS, it vital understand there need adju...